WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004093996) TOPICAL SULFACETAMIDE COMPOSITION AND METHOD FOR TREATING SEBORRHEIC DERMATITIS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/093996    International Application No.:    PCT/US2004/008047
Publication Date: 04.11.2004 International Filing Date: 17.03.2004
Chapter 2 Demand Filed:    18.11.2004    
IPC:
A61K 31/18 (2006.01), A61Q 19/10 (2006.01)
Applicants: HEALTHPOINT, LTD [US/US]; 3909 Hulen Street, Fort Worth, TX 76107 (US) (For All Designated States Except US).
SHROOT, Braham [US/US]; (US) (For US Only).
ESPINOZA, Robert [US/US]; (US) (For US Only).
WILLIS, Jimmy Joe [US/US]; (US) (For US Only)
Inventors: SHROOT, Braham; (US).
ESPINOZA, Robert; (US).
WILLIS, Jimmy Joe; (US)
Agent: SEASE, Edmund, J.; McKee, Voorhees & Sease, PLC, 801 Grand Avenue, Suite 3200, Des Moines, IA 50309 (US)
Priority Data:
10/406,412 03.04.2003 US
Title (EN) TOPICAL SULFACETAMIDE COMPOSITION AND METHOD FOR TREATING SEBORRHEIC DERMATITIS
(FR) COMPOSITION TOPIQUE A BASE DE SULFACETAMIDE ET PROCEDE DE TRAITEMENT DE DERMATITE SEBORRHEIQUE
Abstract: front page image
(EN)A topical composition and method for treating seborrehic dermatitis designed specifically to allow for short duration skin contact time. It is a water rinseable sulfacetamide composition free of elemental sulfur, preferably dosed in a regimen of at least two daily treatments.
(FR)L'invention concerne une composition topique et un procédé de traitement de dermatite séborrhéique, ladite composition étant spécifiquement destinée à être mise en contact avec la peau pendant une courte durée. Cette composition à base de sulfacétamide rinçable à l'eau est dépourvue de soufre élémentaire, et est de préférence administrée selon un régime d'au moins deux doses thérapeutiques journalières.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)